Albert B. Jeon
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Mycobacterium research and diagnosis, Tuberculosis Research and Epidemiology, Antibiotic Resistance in Bacteria, SARS-CoV-2 and COVID-19 Research, Influenza Virus Research Studies
Most-Cited Works
- → Surface-fill hydrogel attenuates the oncogenic signature of complex anatomical surface cancer in a single application(2021)87 cited
- → Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection(2023)69 cited
- → A spectrum of segmental multicystic renal dysplasia(1999)48 cited
- → Shell Lesions Associated With Emydomyces testavorans Infection in Freshwater Aquatic Turtles(2021)41 cited
- → Capsular serotypes, virulence-associated genes and antimicrobial susceptibility of <i>Streptococcus suis</i> isolates from pigs in Korea(2017)35 cited
- → 2-aminoimidazoles collapse mycobacterial proton motive force and block the electron transport chain(2019)31 cited
- → 2-aminoimidazoles potentiate ß-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing ß-lactamase secretion and increasing cell envelope permeability(2017)25 cited
- → The Discovery of 2‐Aminobenzimidazoles That Sensitize Mycobacterium smegmatis and M. tuberculosis to β‐Lactam Antibiotics in a Pattern Distinct from β‐Lactamase Inhibitors(2017)25 cited
- → BRCA2-DSS1 interaction is dispensable for RAD51 recruitment at replication-induced and meiotic DNA double strand breaks(2022)24 cited